UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009

Emerging infectious diseases, 2015-01, Vol.21 (1), p.23-31

2015

Volltextzugriff (PDF)

Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule

Viruses, 2019-08, Vol.11 (9), p.807

2019

Volltextzugriff (PDF)

Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit

Emerging infectious diseases, 2008-06, Vol.14 (6), p.881-887

2008

Volltextzugriff (PDF)

Laboratory exposures to staphylococcal enterotoxin B

Emerging infectious diseases, 2004-09, Vol.10 (9), p.1544-1549

2004

Volltextzugriff (PDF)

Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

The Lancet infectious diseases, 2020-04, Vol.20 (4), p.455-466

2020

Volltextzugriff (PDF)

Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule

Comparative medicine, 2018-10, Vol.68 (5), p.380-395

2018

Volltextzugriff (PDF)

Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics

Toxicon (Oxford), 2019-09, Vol.167, p.152-161

2019

Volltextzugriff (PDF)

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study

Vaccine, 2011-04, Vol.29 (17), p.3222-3229

2011

Volltextzugriff (PDF)

Botulism: Cause, Effects, Diagnosis, Clinical and Laboratory Identification, and Treatment Modalities

Disaster medicine and public health preparedness, 2007-11, Vol.1 (2), p.122-134

2007

Volltextzugriff (PDF)

Botulinum neurotoxin vaccines: past, present, and future

Critical reviews in immunology, 2007, Vol.27 (4), p.303-318

2007

Volltextzugriff (PDF)

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

Antiviral research, 2009-01, Vol.81 (1), p.68-76

2009

Volltextzugriff (PDF)

Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)

Journal of occupational and environmental medicine, 2004-08, Vol.46 (8), p.801-811

2004

Volltextzugriff (PDF)

Clinical Gnathostomiasis: Case Report and Review of the English-Language Literature

Clinical infectious diseases, 1993-01, Vol.16 (1), p.33-50

1993

Volltextzugriff (PDF)

Management guidelines for laboratory exposures to agents of bioterrorism

Journal of occupational and environmental medicine, 2004-08, Vol.46 (8), p.791-800

2004

Volltextzugriff (PDF)

Reaction after smallpox vaccination

American family physician, 2006-07, Vol.74 (1), p.145

2006

Volltextzugriff (PDF)

History of U.S. military contributions to the study of parasitic diseases

Military medicine, 2005-04, Vol.170 (4 Suppl), p.17-29

2005

Volltextzugriff (PDF)

Botulinum Neurotoxin Vaccines: Past history and recent developments

Human vaccines, 2009-12, Vol.5 (12), p.794-805

2009

Volltextzugriff (PDF)

Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers

Biosecurity and bioterrorism, 2004-01, Vol.2 (4), p.281-293

2004

Volltextzugriff (PDF)

1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S616-S616

2021

Volltextzugriff (PDF)

Experience with Ribavirin for Treatment and Postexposure Prophylaxis of Hemorrhagic Fever Viruses: Crimean Congo Hemorrhagic Fever, Lassa Fever, and Hantaviruses

Applied biosafety, 2011-06, Vol.16 (2), p.67-87

Rusnak, Janice M.

2011

Volltextzugriff (PDF)

Botulinum Neurotoxin Vaccines: Past history and recent developments

Human vaccines & immunotherapeutics, 2009-12, Vol.5 (12), p.794-805

2009

Volltextzugriff (PDF)

Photo Quiz: Reaction After Smallpox Vaccination

American family physician, 2006-07, Vol.74 (1), p.145

2006

Volltextzugriff (PDF)

Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit super(1)

Emerging infectious diseases, 2008-06, Vol.14 (6), p.881-887

2008

Volltextzugriff (PDF)

Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit1

Emerging infectious diseases, 2008-06, Vol.14 (6), p.881-887

2008

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(38)
Buchkapitel
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(24)
Immunology
(13)
Infectious Diseases
(13)
Male
(9)
Biological And Medical Sciences
(8)
Female
(8)
Microbiology
(8)
Vaccines
(8)
Adult
(7)
Aids/hiv
(6)
Public, Environmental & Occupational Health
(6)
United States
(6)
Animals
(5)
Bioterrorism
(5)
Hiv
(5)
Hiv Infections - Immunology
(5)
Human Immunodeficiency Virus
(5)
Ebola Virus
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009

Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule

Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit

Laboratory exposures to staphylococcal enterotoxin B

Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule

Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study

Botulism: Cause, Effects, Diagnosis, Clinical and Laboratory Identification, and Treatment Modalities

Botulinum neurotoxin vaccines: past, present, and future

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)

Clinical Gnathostomiasis: Case Report and Review of the English-Language Literature

Management guidelines for laboratory exposures to agents of bioterrorism

Reaction after smallpox vaccination

History of U.S. military contributions to the study of parasitic diseases

Botulinum Neurotoxin Vaccines: Past history and recent developments

Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers

1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV

Experience with Ribavirin for Treatment and Postexposure Prophylaxis of Hemorrhagic Fever Viruses: Crimean Congo Hemorrhagic Fever, Lassa Fever, and Hantaviruses

Botulinum Neurotoxin Vaccines: Past history and recent developments

Photo Quiz: Reaction After Smallpox Vaccination

Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit super(1)

Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit1

Suchergebnisse filtern